Sandhya Healthcare Remedy Impel Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.20 M
- Company Age 18 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.08 M
- Revenue Growth 9.29%
- Profit Growth 20.13%
- Ebitda -16.28%
- Net Worth 2.35%
- Total Assets -12.83%
About Sandhya Healthcare Remedy Impel
Sandhya Healthcare Remedy Impel Private Limited (SHRIPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 November 2006 and has a history of 18 years and three months. Its registered office is in Haridwar, Uttarakhand, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹4.08 M.
Sandhya Bhatnagar and Abhishek Bhatnagar serve as directors at the Company.
Company Details
-
Location
Haridwar, Uttarakhand, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232UR2006PTC032327
-
Company No.
032327
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Nov 2006
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Uttarakhand
Industry
Who are the key members and board of directors at Sandhya Healthcare Remedy Impel?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandhya Bhatnagar
|
Director | 06-Nov-2006 | Current |
|
Abhishek Bhatnagar
|
Director | 06-Nov-2006 | Current |
Financial Performance of Sandhya Healthcare Remedy Impel.
Sandhya Healthcare Remedy Impel Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 9.29% increase. The company also saw a substantial improvement in profitability, with a 20.13% increase in profit. The company's net worth moved up by a moderate rise of 2.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sandhya Healthcare Remedy Impel?
In 2022, Sandhya Healthcare Remedy Impel had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Bhatnagar Cardiac Care Private LimitedSandhya Bhatnagar is a mutual person
-
Parrot & Lily Private Limited
Abhishek Bhatnagar is a mutual person
-
Bhatnagar Hospital Private Limited
Abhishek Bhatnagar is a mutual person
Charges (Loans)
₹4.08 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.41 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Mar 2012 | State Bank Of India | ₹4.08 M | Open |
How Many Employees Work at Sandhya Healthcare Remedy Impel?
Sandhya Healthcare Remedy Impel has a workforce of 3 employees as of Mar 20, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sandhya Healthcare Remedy Impel, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sandhya Healthcare Remedy Impel's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
